JP2012531896A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012531896A5 JP2012531896A5 JP2012517837A JP2012517837A JP2012531896A5 JP 2012531896 A5 JP2012531896 A5 JP 2012531896A5 JP 2012517837 A JP2012517837 A JP 2012517837A JP 2012517837 A JP2012517837 A JP 2012517837A JP 2012531896 A5 JP2012531896 A5 JP 2012531896A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- cells
- mammal
- functional
- human mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22143809P | 2009-06-29 | 2009-06-29 | |
| US61/221,438 | 2009-06-29 | ||
| PCT/US2010/040260 WO2011002727A1 (en) | 2009-06-29 | 2010-06-28 | Methods of producing humanized non-human mammals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012531896A JP2012531896A (ja) | 2012-12-13 |
| JP2012531896A5 true JP2012531896A5 (cg-RX-API-DMAC7.html) | 2013-08-15 |
Family
ID=43411395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012517837A Pending JP2012531896A (ja) | 2009-06-29 | 2010-06-28 | ヒト化非ヒト哺乳動物を製造する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120157667A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2449094A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012531896A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102725400A (cg-RX-API-DMAC7.html) |
| SG (2) | SG10201403703XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011002727A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4502152A3 (en) | 2009-10-06 | 2025-04-30 | Regeneron Pharmaceuticals, Inc. | Genetically modified mice and engraftment |
| PT4233537T (pt) | 2011-02-15 | 2025-09-08 | Regeneron Pharma | Ratinhos humanizados para m-csf e utilizações dos mesmos |
| WO2013086019A1 (en) * | 2011-12-06 | 2013-06-13 | Massachusetts Institute Of Technology | Use of humanized mice to determine toxicity |
| CN103387955B (zh) * | 2012-05-10 | 2015-04-29 | 上海南方模式生物科技发展有限公司 | 非人哺乳动物b淋巴细胞缺陷动物模型的制备方法及其用途 |
| WO2014039733A1 (en) * | 2012-09-05 | 2014-03-13 | University Of Southern California | Methods and compositions for detecting, imaging, and treating small cell lung cancer utilizing post-translationally modified residues and higher molecular weight antigenic complexes in proteins |
| KR102241962B1 (ko) * | 2012-09-07 | 2021-04-20 | 예일 유니버시티 | 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법 |
| DK4389764T3 (da) * | 2012-11-05 | 2026-04-13 | Regeneron Pharma | Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf |
| WO2014121840A1 (en) * | 2013-02-07 | 2014-08-14 | Medizinische Hochschule Hannover | Induced dendritic cells and uses thereof |
| WO2014196929A1 (en) * | 2013-06-05 | 2014-12-11 | Agency For Science, Technology And Research | A humanized mouse model for study of bona fide hepatitis virus infection and use thereof |
| NO2785538T3 (cg-RX-API-DMAC7.html) * | 2014-05-07 | 2018-08-04 | ||
| EP3482629B1 (en) * | 2014-05-19 | 2020-11-25 | Regeneron Pharmaceuticals, Inc. | Genetically modified non-human animals expressing human epo |
| ES2950399T3 (es) | 2015-04-13 | 2023-10-09 | Regeneron Pharma | Ratones humanizados Sirpa-IL15 insertados y métodos de uso de los mismos |
| JP6654001B2 (ja) * | 2015-05-27 | 2020-02-26 | 公益財団法人実験動物中央研究所 | ヒトil−15分泌免疫不全マウス |
| EP3383173B1 (en) * | 2015-11-30 | 2020-11-25 | H. Hoffnabb-La Roche Ag | Generation of human macrophages in immunodeficient mice |
| US20200315147A1 (en) * | 2017-11-17 | 2020-10-08 | University Of Tsukuba | Non-human animal and method for producing same |
| CN111304248B (zh) | 2018-12-25 | 2021-08-24 | 百奥赛图江苏基因生物技术有限公司 | 人源化细胞因子il15基因改造非人动物的构建方法及应用 |
| CN111172190B (zh) * | 2018-12-25 | 2021-07-30 | 百奥赛图江苏基因生物技术有限公司 | 人源化细胞因子csf2基因改造非人动物的构建方法及应用 |
| WO2020157997A1 (ja) * | 2019-01-28 | 2020-08-06 | 公益財団法人実験動物中央研究所 | ヒトil-34を有する非ヒト動物及びその使用 |
| CN113677199A (zh) * | 2019-02-13 | 2021-11-19 | 杰克逊实验室 | 支持先天免疫功能的转基因小鼠模型 |
| US20220192166A1 (en) * | 2019-03-28 | 2022-06-23 | Central Institute For Experimental Animals | Immunodeficient rodent |
| CN111485001A (zh) * | 2020-04-14 | 2020-08-04 | 澎立生物医药技术(上海)有限公司 | 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法 |
| US20230340524A1 (en) * | 2020-07-08 | 2023-10-26 | The Jackson Laboratory | Transgenic mouse models supporting human innate immune function |
| CN112042597B (zh) * | 2020-07-22 | 2022-04-29 | 南京普恩瑞生物科技有限公司 | 一种双人源化肿瘤异种移植模型的构建方法 |
| CN114853871B (zh) * | 2021-04-20 | 2024-04-05 | 百奥赛图(北京)医药科技股份有限公司 | Csf1和/或csf1r基因人源化的非人动物及其构建方法和应用 |
| CN117070524A (zh) * | 2022-08-15 | 2023-11-17 | 江苏集萃药康生物科技股份有限公司 | 一种白介素人源化的非人动物的制备方法及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3853201T2 (de) * | 1987-12-23 | 1995-09-14 | Univ Leland Stanford Junior | Schimäre immunkompromittierende Säugetiere und ihre Verwendung. |
| US5639939A (en) * | 1987-12-23 | 1997-06-17 | The Board Of Trustees For The Leland Stanford Junior University | Chimeric immunocompromised mammal comprosing vascularized fetal organ tissue |
| JPH09506626A (ja) * | 1993-12-17 | 1997-06-30 | システミクス・インコーポレイテッド | 非自己造血細胞移植片の生存延長のためのマクロファージ枯渇剤の使用および動物モデル検定系 |
| US6015554A (en) * | 1995-06-07 | 2000-01-18 | Systemix, Inc. | Method of reconstituting human lymphoid and dendritic cells |
| US6060643A (en) * | 1995-08-04 | 2000-05-09 | Emory University | Mouse model with human immune system |
| US20070021364A1 (en) * | 1995-12-13 | 2007-01-25 | Hans Herweijer | Methods for genetic immunization |
| WO1999061589A2 (en) * | 1998-05-28 | 1999-12-02 | St. Jude Children's Research Hospital | Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof |
| AU4323599A (en) * | 1998-05-29 | 1999-12-13 | Instituto Superiore Di Sanita | Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| JP2006501177A (ja) * | 2002-06-24 | 2006-01-12 | ジェンザイム・コーポレイション | 遺伝子治療薬を送達する方法 |
| GB0406728D0 (en) * | 2004-03-25 | 2004-04-28 | Hydrodynamic Gene Delivery Ltd | Gene therapy |
| US8252587B2 (en) * | 2004-10-25 | 2012-08-28 | Celerant Therapeutics, Inc. | Methods of expanding myeloid cell populations and uses thereof |
| AU2007238660C1 (en) * | 2006-04-14 | 2013-11-07 | Astellas Institute For Regenerative Medicine | Hemangio-colony forming cells |
| CA2680613A1 (en) * | 2007-03-13 | 2008-09-18 | National Jewish Medical And Research Center | Methods for generation of antibodies |
| CA2636876A1 (en) * | 2008-02-25 | 2009-08-25 | Gestion Univalor Inc. | Methods and kits for expanding hematopoietic stem cells |
| WO2010115115A1 (en) * | 2009-04-03 | 2010-10-07 | Inserm ( Institut National De La Sante Et De La Recherche) | Dendritic cell-boosted humanized immune system mice |
| SG10201403707QA (en) * | 2009-06-29 | 2014-10-30 | Ilya B Leskov | Non-human mammal model of human hematopoietic cancer |
| EP4502152A3 (en) * | 2009-10-06 | 2025-04-30 | Regeneron Pharmaceuticals, Inc. | Genetically modified mice and engraftment |
-
2010
- 2010-06-28 SG SG10201403703XA patent/SG10201403703XA/en unknown
- 2010-06-28 US US13/381,313 patent/US20120157667A1/en not_active Abandoned
- 2010-06-28 WO PCT/US2010/040260 patent/WO2011002727A1/en not_active Ceased
- 2010-06-28 EP EP10794611.3A patent/EP2449094A4/en not_active Withdrawn
- 2010-06-28 CN CN2010800388479A patent/CN102725400A/zh active Pending
- 2010-06-28 JP JP2012517837A patent/JP2012531896A/ja active Pending
- 2010-06-28 SG SG2011084647A patent/SG176118A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Martinov et al. | Building the next generation of humanized hemato-lymphoid system mice | |
| De La Rochere et al. | Humanized mice for the study of immuno-oncology | |
| Wege | Humanized mouse models for the preclinical assessment of cancer immunotherapy | |
| AU2018202976B2 (en) | Polyclonal gamma delta t cells for immunotherapy | |
| Majc et al. | Immunotherapy of glioblastoma: current strategies and challenges in tumor model development | |
| Calmeiro et al. | Dendritic cell vaccines for cancer immunotherapy: the role of human conventional type 1 dendritic cells | |
| Cho et al. | A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells | |
| CN102725400A (zh) | 制造人源化的非人类哺乳动物的方法 | |
| Hara et al. | Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region | |
| ES2700852T3 (es) | Ratones modificados genéticamente e injerto | |
| Salguero et al. | Dendritic cell–mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation | |
| IL299249B1 (en) | Genetically modified immune cells that include adapted shrna-microRNA (shrnamir) | |
| Bemark et al. | Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation–revelation of B cell developmental pathways and lineage phenotypes | |
| JP2015534819A5 (cg-RX-API-DMAC7.html) | ||
| EP4251177A2 (en) | Antigen specific t cells and methods of making and using same | |
| EP2495312A1 (en) | Method for producing antigen-specific b cell population | |
| Ren et al. | Translational models in glioma immunotherapy research | |
| Eguren-Santamaria et al. | Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic | |
| Ghasemi et al. | Dendritic cell progenitors engineered to express extracellular-vesicle–internalizing receptors enhance cancer immunotherapy in mouse models | |
| Akkina | Humanized mice for studying human immune responses and generating human monoclonal antibodies | |
| Läderach et al. | MHC class II‐deficient mice allow functional human CD4+ T‐cell development | |
| Xun et al. | Induced pluripotent stem cell-based cancer immunotherapy: strategies and perspectives | |
| DOYLE et al. | The CD4+ T‐cell response to protein immunization is independent of accompanying IFN‐γ‐producing CD8+ T cells | |
| C Harman et al. | Antibody discovery from immune competent and immune transplanted mice | |
| Patel et al. | Diverse T‐cell differentiation potentials of human fetal thymus, fetal liver, cord blood and adult bone marrow CD34 cells on lentiviral Delta‐like‐1‐modified mouse stromal cells |